1.A cohort study on the association between prenatal exposure to fluorinated liquid crystal monomers and offspring growth from birth to age 8
Hang SU ; Chenhui SANG ; Yao CHEN ; Tao YING ; Runhui YANG ; Qiao KE ; Yuwei LIU ; Maohua MIAO ; Bing SHAO ; Gengsheng HE
Shanghai Journal of Preventive Medicine 2026;38(9):653-662
ObjectiveTo systematically evaluate the associations between prenatal exposure to fluorinated liquid-crystal monomers (FLCMs) and offspring growth and development from birth to age 8 based on a prospective birth cohort, to identify potential key chemicals, and to provide prospective epidemiological evidence for elucidating the health risks associated with early-life exposure to FLCMs. MethodsA total of 173 mother-infant pairs from the Shanghai-Minhang Birth Cohort Study were included. Concentrations of 39 FLCMs in maternal urine samples collected during the third trimester were measured using gas chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry. Multiple linear regression models and generalized estimating equations (GEE) were used to assess the cross-sectional and longitudinal associations between prenatal exposure to FLCMs and anthropometric measurements in offspring, including weight, length/height, head circumference, upper arm circumference, abdominal circumference, skinfold thickness (abdominal, triceps, and back), BMI-for-age Z-score, height-for-age Z-score, and weight-for-age Z-score, at various time points (birth, 6 months, 1 year, 4 years, 6 years, and 8 years). Group-based trajectory modeling (GBTM) was used to identify typical growth trajectories of offspring, and multivariate logistic regression models were used to evaluate the association between prenatal exposure to FLCMs and trajectory group membership. ResultsThe geometric mean concentrations of FLCMs in maternal urine samples ranged from 0.002 to 0.257 μg∙g-1, with the highest concentration observed for 1-ethyl-4-[(4-fluorophenyl) ethynyl] benzene (EFPEB) at 0.257 μg∙g-1, followed by 4-cyano-3-fluorophenyl-4-ethylbenzoate (CFPEB) at 0.085 μg∙g-1. Multiple linear regression indicated that prenatal exposure to 4-ethoxy-2,3-difluoro-4-(4-propylphenyl)-benzene (EDPBB) was significantly negatively associated with offspring head circumference (6 months: β=-0.240; 1 year: β=-0.330; 6 years: β=-0.224; 8 years: β=-0.325), height-for-age Z-score(6 years: β=-0.151; 8 years: β=-0.148), weight-for-age Z-score (6 years: β=-0.189; 8 years: β=-0.219), and other indicators. GEE models further confirmed that prenatal exposure to EDPBB was negatively associated with BMI-for-age Z-score (β=-0.127), height-for-age Z-score (β=-0.085), and weight-for-age Z-score (β=-0.139) throughout the follow-up period from birth to age 8. GBTM identified two distinct growth trajectories, including a low-growth group and a high-growth group. Multivariate logistic regression showed that prenatal exposure to EDPBB was negatively associated with the risk of belonging to the high-growth trajectory (BMI-for-age Z-score: OR=0.627, P=0.035; weight-for-age Z-score: OR=0.620, P=0.020). ConclusionPrenatal exposure to FLCMs, particularly EDPBB, may exert sustained and progressive negative effects on offspring growth and development from birth to age 8. This study provides prospective cohort evidence for the health risks associated with early-life exposure to FLCMs.

Result Analysis
Print
Save
E-mail